Colorectal News and Research

RSS

Geisinger CEO wins 2010 TRUST Award

The Health Research & Educational Trust (HRET), an affiliate of the American Hospital Association (AHA), has selected Glenn D. Steele Jr., MD, PhD president and chief executive officer of Geisinger Health System, as the recipient of the 2010 TRUST Award.

18 Jan 2010

New research shows cutting tobacco smoking reduces cancer deaths in Europe

New research on deaths from cancer in Europe concludes that the key priority for continuing to reduce mortality is cutting tobacco smoking. The study shows that, while deaths for men from lung cancer in the EU have declined overall, by 17 % from 1995 to 2004, they rose by 27% for women over the same period.

17 Jan 2010

TD2 and COTI work together to obtain approval of clinical trials for COTI-2

TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.

12 Jan 2010

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.

12 Jan 2010

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

A new national survey reveals that while almost all Canadians understand the importance of getting checked for colon cancer, most have not had a screening test and are confused about how and when it should happen.

8 Jan 2010

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

Following the results of the Angus Reid Strategies and the Applied Health Research Centre at Toronto's St. Michael's Hospital survey conducted on behalf of the Canadian Partnership Against Cancer finding that the majority of Canadians have a good understanding of the benefits of colorectal cancer screening, but are not taking action to get screened, the Colorectal Cancer Association of Canada ("CCAC") is doubling its efforts in 2010 to convince Canadians that they must be more proactive concerning their health and the onset of colorectal cancer.

7 Jan 2010

Data highlights importance of follow-up exams for patients with history of advanced adenomas

A new study examines the occurrence of interval colorectal cancer despite regular colonoscopy and highlights the importance of close follow-up for patients who have a history of advanced adenomas, which are precancerous polyps.

7 Jan 2010

Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).

6 Jan 2010

Wisconsin rural hospitals hope for federal money to offset state Medicaid cut

Wisconsin's rural hospitals hope to offset a state Medicaid cut with a tax that would bring more federal money to the hospitals. The proposed tax on the state's 59 'critical access' hospitals, all in rural areas, would prevent the hospitals from closing important services, officials say.

5 Jan 2010

JumpStart announces two JumpStart Ventures investments

JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announces two JumpStart Ventures investments.

31 Dec 2009

Researchers study the effectiveness of colonoscopy in preventing colorectal cancer

The prevalence of left-sided advanced colorectal neoplasms was lower in participants in a community setting, but not right-sided advanced neoplams, who had received a colonoscopy in the preceding 10 years, according to a new study published online December 30 in the Journal of the National Cancer Institute.

31 Dec 2009

CGEN-671, a new drug target for multiple epithelial tumors discovered by Compugen

Compugen Ltd. announced today the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors.

28 Dec 2009

MSH6 mutation carriers at elevated risk for colorectal, endometrial and lynch syndrome cancers

People carrying the germ-line MSH6 mutation are at high risk by age 80 years for colorectal and endometrial cancers and any cancer associated with Lynch syndrome, according to a new study published online December 22 in the Journal of the National Cancer Institute.

23 Dec 2009

First robot-assisted lung-tumor surgery performed at UT Southwestern Medical Center

When Craig Harrison found out he would be the first patient in North Texas to have robot-assisted lung-tumor surgery, an operation performed at UT Southwestern Medical Center, he wasn't nervous at all.

22 Dec 2009

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.

21 Dec 2009

Joe Chimera, the 25th person to receive MEP Certification from PHII

The Population Health Impact Institute (PHII) is pleased to announce that Joe Chimera, Ph.D., is the 25th person to receive the Methods Evaluation Process (MEP) Certification.

18 Dec 2009

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

NiTi™ Surgical Solutions, an innovative surgical device company, today announced that its ColonRing™, the first major advance in closure for gastrointestinal surgery in more than 30 years, has been used for the first time in a colorectal surgery in China. The ColonRing anastomosis device was launched in the United States in May 2008 and has been successfully applied in thousands of patients.

18 Dec 2009

GSTM1 and GSTT1 null genotypes not associated with increased risk of GC or CRC in Koreans

The glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null genotypes have been linked to increased risk of developing cancer. The results regarding the association between GSTM1 and GSTT1 null genotypes and the risk of GC or CRC were contradictory.

18 Dec 2009

New study to examine physical activity and dietary behavior of colorectal cancer patients

In an effort to build the groundwork for future research on health promotion among individuals with colorectal and other cancers, a team of investigators at The Cancer Institute of New Jersey (CINJ) has launched a new study examining patterns in physical activity and eating habits of colorectal cancer patients who have recently finished treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

18 Dec 2009

$15 million federal funds for new cancer research program

As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

17 Dec 2009

Colorectal News and Research

Geisinger CEO wins 2010 TRUST Award

New research shows cutting tobacco smoking reduces cancer deaths in Europe

TD2 and COTI work together to obtain approval of clinical trials for COTI-2

New blood test to identify changes in DNA linked with colorectal cancer now available in the U.S.

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

Data highlights importance of follow-up exams for patients with history of advanced adenomas

Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

Wisconsin rural hospitals hope for federal money to offset state Medicaid cut

JumpStart announces two JumpStart Ventures investments

Researchers study the effectiveness of colonoscopy in preventing colorectal cancer

CGEN-671, a new drug target for multiple epithelial tumors discovered by Compugen

MSH6 mutation carriers at elevated risk for colorectal, endometrial and lynch syndrome cancers

First robot-assisted lung-tumor surgery performed at UT Southwestern Medical Center

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Joe Chimera, the 25th person to receive MEP Certification from PHII

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

GSTM1 and GSTT1 null genotypes not associated with increased risk of GC or CRC in Koreans

New study to examine physical activity and dietary behavior of colorectal cancer patients

$15 million federal funds for new cancer research program

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News